Search clinical trials for: SB656933

Total 6 results

GlaxoSmithKline

Terminated

Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis

Colitis, Ulcerative

Netherlands
GlaxoSmithKline

Completed

28 Day Repeat Dose in Cystic Fibrosis Patients

Cystic Fibrosis

United States, France, Germany, Israel, Canada
GlaxoSmithKline

Completed

SD Cystic Fibrosis Study

Cystic Fibrosis

United States
GlaxoSmithKline

Completed

Repeat Dose Study in Male Healthy Volunteer Smokers

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

Pulmonary Disease, Chronic Obstructive

Germany
GlaxoSmithKline

Completed

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom

3

Subscribe